Home Blog of Signal Transduction Apoptosis TNF-alpha The Mystery of EVP4593: Perspectives of the Quinazoline-Derived Compound in the Treatment of Huntington's Disease and Other Human Pathologies

Category

Archives

Popular Post

ESKM, a novel therapeutic agent for sensitive and resistant PH+ leukemias

The mechanism of resistance to JAK2 inhibitor in myeloproliferative neoplasms patients

Effects of PARP inhibitors in BRCA gene-mutated ovarian cancer

DASATINIB; An inhibitor of Receptor Tyrosine Kinase

GP130/JAK/STAT3 signaling pathway induces multiple myeloma

The Mystery of EVP4593: Perspectives of the Quinazoline-Derived Compound in the Treatment of Huntington's Disease and Other Human Pathologies

Quinazoline derivatives have various pharmacological activities and are widely used in clinical practice. Here, we reviewed the proposed mechanisms of the physiological activity of the quinazoline derivative EVP4593 and perspectives for its clinical implication. We summarized the accumulated data about EVP4593 and focused on its activities in different models of Huntington's disease (HD), including patient-specific iPSCs-based neurons. To make a deeper insight into its neuroprotective role in HD treatment, we discussed the ability of EVP4593 to modulate calcium signaling and reduce the level of the huntingtin protein. Moreover, we described possible protective effects of EVP4593 in other pathologies, such as oncology, cardiovascular diseases and parasite invasion. We hope that comprehensive analyses of the molecular mechanisms of EVP4593 activity will allow for the expansion of the scope of the EVP4593 application.

 

Comments：

It is interesting to note that quinazoline derivatives, including EVP4593, have a wide range of pharmacological activities and have shown promising results in various clinical applications. The proposed mechanisms of action for EVP4593 suggest its potential as a therapeutic agent in Huntington's disease, as well as other pathologies such as oncology, cardiovascular diseases, and parasite invasion.

The ability of EVP4593 to modulate calcium signaling and reduce the level of the huntingtin protein provides insight into its neuroprotective role in HD treatment. This could potentially slow or even reverse the disease progression, which would be a major breakthrough in the field of HD research.

In addition to its use in HD treatment, the potential protective effects of EVP4593 in other pathologies such as oncology and cardiovascular diseases suggest that it may have a broader therapeutic potential.

Overall, a deeper understanding of the molecular mechanisms of EVP4593 activity could potentially expand its application and provide new insights into the treatment of a range of diseases.